"Gadolinium DTPA" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A complex of gadolinium with a chelating agent, diethylenetriamine penta-acetic acid (DTPA see PENTETIC ACID), that is given to enhance the image in cranial and spinal MRIs. (From Martindale, The Extra Pharmacopoeia, 30th ed, p706)
Descriptor ID |
D019786
|
MeSH Number(s) |
D02.092.782.590.401 D02.241.081.018.639.400 D02.691.400
|
Concept/Terms |
Gadolinium DTPA- Gadolinium DTPA
- DTPA, Gadolinium
- Gadolinium Diethylenetriaminepenta-acetic Acid
- Diethylenetriaminepenta-acetic Acid, Gadolinium
- Gadolinium Diethylenetriaminepenta acetic Acid
- Gadopentetic Acid
- Gd-DTPA
- Gd DTPA
Gadopentetate Dimeglumine- Gadopentetate Dimeglumine
- Dimeglumine, Gadopentetate
- Gadolinium DTPA Dimeglumine Salt
- Gadolinium DTPA Dimeglumine
- Dimeglumine, Gadolinium DTPA
|
Below are MeSH descriptors whose meaning is more general than "Gadolinium DTPA".
Below are MeSH descriptors whose meaning is more specific than "Gadolinium DTPA".
This graph shows the total number of publications written about "Gadolinium DTPA" by people in this website by year, and whether "Gadolinium DTPA" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 0 | 2 | 2 |
1995 | 0 | 1 | 1 |
1996 | 0 | 2 | 2 |
1997 | 0 | 2 | 2 |
1998 | 2 | 0 | 2 |
1999 | 0 | 1 | 1 |
2001 | 0 | 1 | 1 |
2002 | 2 | 1 | 3 |
2003 | 1 | 1 | 2 |
2004 | 2 | 2 | 4 |
2005 | 3 | 3 | 6 |
2006 | 2 | 3 | 5 |
2007 | 6 | 6 | 12 |
2008 | 5 | 3 | 8 |
2009 | 3 | 4 | 7 |
2010 | 6 | 8 | 14 |
2011 | 1 | 5 | 6 |
2012 | 6 | 0 | 6 |
2013 | 1 | 12 | 13 |
2014 | 2 | 5 | 7 |
2015 | 2 | 3 | 5 |
2017 | 1 | 2 | 3 |
2020 | 0 | 1 | 1 |
2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Gadolinium DTPA" by people in Profiles.
-
Temporal Changes on Postgadolinium MR Vessel Wall Imaging Captures Enhancement Kinetics of Intracranial Atherosclerotic Plaques and Aneurysms. AJNR Am J Neuroradiol. 2024 Sep 09; 45(9):1206-1213.
-
Regional myocardial strain by cardiac magnetic resonance feature tracking for detection of scar in ischemic heart disease. Magn Reson Imaging. 2020 05; 68:190-196.
-
Comparison of region-of-interest-averaged and pixel-averaged analysis of DCE-MRI data based on simulations and pre-clinical experiments. Phys Med Biol. 2017 Sep 05; 62(18):N445-N459.
-
MRI ductography of contrast agent distribution and leakage in normal mouse mammary ducts and ducts with in situ cancer. Magn Reson Imaging. 2017 07; 40:48-52.
-
Prolactin Receptor-Mediated Internalization of Imaging Agents Detects Epithelial Ovarian Cancer with Enhanced Sensitivity and Specificity. Cancer Res. 2017 04 01; 77(7):1684-1696.
-
IV Administered Gadodiamide Enters the Lumen of the Prostatic Glands: X-Ray Fluorescence Microscopy Examination of a Mouse Model. AJR Am J Roentgenol. 2015 Sep; 205(3):W313-9.
-
Placental perfusion in uterine ischemia model as evaluated by dynamic contrast enhanced MRI. J Magn Reson Imaging. 2015 Sep; 42(3):666-72.
-
Comparison of dynamic contrast-enhanced MRI parameters of breast lesions at 1.5 and 3.0?T: a pilot study. Br J Radiol. 2015 May; 88(1049):20150021.
-
MRI phenotype of breast cancer: Kinetic assessment for molecular subtypes. J Magn Reson Imaging. 2015 Oct; 42(4):920-4.
-
Dynamic contrast-enhanced magnetic resonance imaging measurements in renal cell carcinoma: effect of region of interest size and positioning on interobserver and intraobserver variability. Invest Radiol. 2015 Jan; 50(1):57-66.